Thanks to my fellow health bloggers for pointing out all the Bostonia in this week’s NEJM:
White Coat Notes points to research on genotyping and lung cancer.
In June, a team led by Boston researchers told a cancer conference about progress against a recently discovered type of lung cancer that affects patients who are younger and less likely to smoke than other people with the disease. The small clinical trial’s results appear in this week’s New England Journal of Medicine, giving more details about a drug that targets a particular genetic abnormality. The preliminary work with an experimental therapy also highlights a different approach to cancer research: going after a specific mutation found in a small group of people instead of casting a wider net for common targets in large numbers of people.
Finally, this week’s Health Wonk Review is up, offering the best of the health policy blogs.